在直肠癌管理中最大限度地降低毒性的新机会
Alice M Couwenberg1, Dimitrios N Varvoglis2, Brian C Grieb3
1Department of Radiation Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
总的新辅助疗法 (TNT) 改善了直肠癌的反应,增加了器官保存的选择. 将免疫疗法与化疗放射治疗结合起来对更多患者来说是有前途的,可能会避免手术.
科学领域:
- 在瘤学瘤学.
- 手术瘤学手术瘤学
- 辐射瘤学 辐射瘤学
背景情况:
- 局部晚期直肠癌 (LARC) 的多模式管理改善了结果,但导致了显著的发病率.
- 总的新辅助疗法 (TNT) 增强了瘤反应和耐受性.
- TNT增加了临床完整反应,使得非手术管理和避免手术并发症.
研究的目的:
- 审查LARC管理方面的进展,重点关注TNT和新兴免疫疗法.
- 探索免疫治疗在特定LARC亚型中的潜力.
- 评估综合治疗策略,以提高器官的保存.
主要方法:
- 对LARC治疗方法的最新临床试验和临床前研究的审查.
- 分析与TNT相关的结果,包括反应率和毒性.
- 研究免疫疗法与标准疗法结合的研究.
主要成果:
- TNT显示了瘤反应的改善和可接受的毒性.
- 与TNT观察到的非手术性,器官保存方法的资格增加.
- 免疫疗法显示出不匹配修复缺陷LARC的潜力,目前正在进行的试验将其与化疗或放射治疗结合起来.
结论:
- 对于LARC来说,TNT是一个有前途的策略,可以改善反应和器官保存.
- 涉及免疫疗法,放射疗法和化疗的组合疗法正在研究中,以最大限度地提高治疗效益并最大限度地降低发病率.
- 未来的LARC管理可能越来越多地涉及器官保存策略,特别是针对特定的分子亚型.
更多相关视频
08:26Clinical Application of Single-Surgeon, Three-Port, Laparoscopic Resection for Colorectal Cancer with Natural Orifice Specimen Extraction
Published on: March 24, 2023
05:32Povidone Iodine Rectal Preparation at Time of Prostate Needle Biopsy is a Simple and Reproducible Means to Reduce Risk of Procedural Infection
Published on: September 21, 2015
相关概念视频
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Prevention of Further Absorption of Poison
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
